𝔖 Bobbio Scriptorium

✦ LIBER ✦

18 Biological activity of a combination of fulvestrant 500 mg (F500) plus anastrozole versus F500 alone or anastrozole alone as neoadjuvant treatment for breast cancer

✍ Scribed by J.F.R. Robertson; J.M. Dixon; D.M. Sibbering; A. Jahan; I.O. Ellis; E. Channon; R.I. Nicholson; J.M.W. Gee

Book ID: 119601036
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)70050-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial to assess the biologi

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer

✍ John FR Robertson, J Michael Dixon, D Mark Sibbering, Ali Jahan… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 185 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB